Shaanxi Micot Pharmaceutical Technology Co., Ltd.

This early-stage study aims to understand how a new experimental drug, MT1013, is processed and eliminated by the body. It will involve 6 adults with a specific bone and mineral disorder related to kidney failure who are on regular dialysis. The main goal is to track where the dr…